BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21363886)

  • 1. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease-the authors' response.
    Reinisch W; Stange EF;
    Gut; 2011 May; 60(5):739-40. PubMed ID: 21363886
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of azathioprine versus mesalazine in postoperative Crohn's disease.
    Ford AC
    Gut; 2010 Dec; 59(12):1731-2. PubMed ID: 20729230
    [No Abstract]   [Full Text] [Related]  

  • 3. Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial.
    Reinisch W; Angelberger S; Petritsch W; Shonova O; Lukas M; Bar-Meir S; Teml A; Schaeffeler E; Schwab M; Dilger K; Greinwald R; Mueller R; Stange EF; Herrlinger KR;
    Gut; 2010 Jun; 59(6):752-9. PubMed ID: 20551460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Azathioprine and 5-ASA in the prevention of postoperative recurrence of Crohn's disease].
    Nos P; Hinojosa J; Aguilera V; Molés JR; Pastor M; Ponce J; Berenguer J
    Gastroenterol Hepatol; 2000 Oct; 23(8):374-8. PubMed ID: 11227650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can the postoperative relapse of Crohn disease be influenced?].
    Jussila A; Färkkilä M; Järvinen HJ
    Duodecim; 2001; 117(8):817-22; quiz 822, 857. PubMed ID: 12116447
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug therapy of Crohn disease].
    Niemelä S
    Duodecim; 2001; 117(8):807-14. PubMed ID: 12116446
    [No Abstract]   [Full Text] [Related]  

  • 7. Adalimumab is more effective than azathioprine and mesalamine at preventing postoperative recurrence of Crohn's disease: a randomized controlled trial.
    Savarino E; Bodini G; Dulbecco P; Assandri L; Bruzzone L; Mazza F; Frigo AC; Fazio V; Marabotto E; Savarino V
    Am J Gastroenterol; 2013 Nov; 108(11):1731-42. PubMed ID: 24019080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring of thiopurine methyltransferase activity in postsurgical patients with Crohn's disease during 1 year of treatment with azathioprine or mesalazine.
    Dilger K; Schaeffeler E; Lukas M; Strauch U; Herfarth H; Müller R; Schwab M
    Ther Drug Monit; 2007 Feb; 29(1):1-5. PubMed ID: 17304143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical therapy to reduce postoperative Crohn's disease recurrence.
    Achkar JP; Hanauer SB
    Am J Gastroenterol; 2000 May; 95(5):1139-46. PubMed ID: 10811318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postoperative recurrence of Crohn's disease, and its prevention].
    Lakatos L; Lakatos PL
    Orv Hetil; 2010 May; 151(21):870-7. PubMed ID: 20462847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current treatment for prevention of relapse and recurrence in Crohn's disease.
    Prantera C; Scribano ML
    Ital J Gastroenterol Hepatol; 1999; 31(6):515-8. PubMed ID: 10575572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for the prevention of postoperative recurrence of Crohn's disease.
    Yamamoto T; Watanabe T
    Colorectal Dis; 2013 Dec; 15(12):1471-80. PubMed ID: 23809911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Postoperative recurrence: adalimumab is an effective standard medication].
    Hofmann-Aßmus M
    Z Gastroenterol; 2014 Mar; 52(3):260. PubMed ID: 24761446
    [No Abstract]   [Full Text] [Related]  

  • 14. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
    González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
    J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of medical therapy in preventing the post-surgical recurrence in Crohn's disease].
    Ardizzone S; Bollani S; Manzionna G; Colombo E; Maconi G; Imbesi V; Bianchi Porro G
    Ann Ital Chir; 2003; 74(6):621-5. PubMed ID: 15206802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.
    Peyrin-Biroulet L; Deltenre P; Ardizzone S; D'Haens G; Hanauer SB; Herfarth H; Lémann M; Colombel JF
    Am J Gastroenterol; 2009 Aug; 104(8):2089-96. PubMed ID: 19568226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial.
    McLeod RS; Wolff BG; Ross S; Parkes R; McKenzie M;
    Dis Colon Rectum; 2009 May; 52(5):919-27. PubMed ID: 19502857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Paradigmatic shift in drug treatment of Crohn disease].
    Munck LK
    Ugeskr Laeger; 2005 Aug; 167(33):3013. PubMed ID: 16109239
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis, prevention and treatment of postoperative Crohn's disease recurrence.
    Buisson A; Chevaux JB; Bommelaer G; Peyrin-Biroulet L
    Dig Liver Dis; 2012 Jun; 44(6):453-60. PubMed ID: 22265329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab versus azathioprine to prevent postoperative recurrence in Crohn's disease: are all controversial issues defined?
    Kotze PG; Yamamoto T
    J Crohns Colitis; 2013 Dec; 7(12):e698. PubMed ID: 23932785
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.